Nu Skin Enterprises EBITDA Margin 2010-2023 | NUS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Nu Skin Enterprises (NUS) over the last 10 years. The current EBITDA margin for Nu Skin Enterprises as of December 31, 2023 is .
| Nu Skin Enterprises EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2023-12-31 |
$1.97B |
$0.12B |
6.09% |
| 2023-09-30 |
$2.00B |
$0.13B |
6.54% |
| 2023-06-30 |
$2.04B |
$0.14B |
6.71% |
| 2023-03-31 |
$2.10B |
$0.15B |
6.99% |
| 2022-12-31 |
$2.23B |
$0.18B |
8.22% |
| 2022-09-30 |
$2.38B |
$0.18B |
7.40% |
| 2022-06-30 |
$2.48B |
$0.26B |
10.60% |
| 2022-03-31 |
$2.62B |
$0.30B |
11.36% |
| 2021-12-31 |
$2.70B |
$0.31B |
11.50% |
| 2021-09-30 |
$2.77B |
$0.38B |
13.65% |
| 2021-06-30 |
$2.83B |
$0.39B |
13.59% |
| 2021-03-31 |
$2.74B |
$0.36B |
12.99% |
| 2020-12-31 |
$2.58B |
$0.33B |
12.82% |
| 2020-09-30 |
$2.42B |
$0.30B |
12.29% |
| 2020-06-30 |
$2.30B |
$0.29B |
12.77% |
| 2020-03-31 |
$2.32B |
$0.31B |
13.43% |
| 2019-12-31 |
$2.42B |
$0.34B |
14.17% |
| 2019-09-30 |
$2.52B |
$0.31B |
12.26% |
| 2019-06-30 |
$2.61B |
$0.32B |
12.39% |
| 2019-03-31 |
$2.69B |
$0.33B |
12.43% |
| 2018-12-31 |
$2.68B |
$0.32B |
12.10% |
| 2018-09-30 |
$2.66B |
$0.40B |
15.14% |
| 2018-06-30 |
$2.55B |
$0.38B |
14.98% |
| 2018-03-31 |
$2.40B |
$0.36B |
15.03% |
| 2017-12-31 |
$2.28B |
$0.35B |
15.18% |
| 2017-09-30 |
$2.14B |
$0.31B |
14.37% |
| 2017-06-30 |
$2.18B |
$0.33B |
14.97% |
| 2017-03-31 |
$2.23B |
$0.34B |
15.35% |
| 2016-12-31 |
$2.21B |
$0.30B |
13.77% |
| 2016-09-30 |
$2.25B |
$0.31B |
13.57% |
| 2016-06-30 |
$2.22B |
$0.27B |
11.96% |
| 2016-03-31 |
$2.18B |
$0.26B |
11.77% |
| 2015-12-31 |
$2.25B |
$0.32B |
14.07% |
| 2015-09-30 |
$2.28B |
$0.34B |
14.97% |
| 2015-06-30 |
$2.35B |
$0.40B |
17.01% |
| 2015-03-31 |
$2.44B |
$0.38B |
15.48% |
| 2014-12-31 |
$2.57B |
$0.41B |
15.80% |
| 2014-09-30 |
$3.02B |
$0.50B |
16.51% |
| 2014-06-30 |
$3.29B |
$0.56B |
16.93% |
| 2014-03-31 |
$3.31B |
$0.61B |
18.48% |
| 2013-12-31 |
$3.18B |
$0.59B |
18.51% |
| 2013-09-30 |
$2.67B |
$0.49B |
18.20% |
| 2013-06-30 |
$2.29B |
$0.40B |
17.47% |
| 2013-03-31 |
$2.21B |
$0.38B |
17.37% |
| 2012-12-31 |
$2.13B |
$0.37B |
17.54% |
| 2012-09-30 |
$2.05B |
$0.36B |
17.59% |
| 2012-06-30 |
$1.95B |
$0.35B |
17.66% |
| 2012-03-31 |
$1.79B |
$0.31B |
17.54% |
| 2011-12-31 |
$1.72B |
$0.27B |
15.47% |
| 2011-09-30 |
$1.65B |
$0.25B |
15.04% |
| 2011-06-30 |
$1.61B |
$0.23B |
14.52% |
| 2011-03-31 |
$1.57B |
$0.23B |
14.40% |
| 2010-12-31 |
$1.54B |
$0.25B |
16.01% |
| 2010-09-30 |
$1.51B |
$0.24B |
15.79% |
| 2010-06-30 |
$1.46B |
$0.23B |
15.51% |
| 2010-03-31 |
$1.40B |
$0.20B |
14.44% |
| 2009-12-31 |
$1.33B |
$0.18B |
13.30% |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Cosmetics and Toiletries |
$0.608B |
$1.969B |
|
Nu Skin develops and distributes a wide range of premium cosmetics, beauty, personal care and wellness products. While the company specializes in beauty and personal care, it also provides a wide range of nutritional products. Nu Skin's products are available in markets worldwide. From a product perspective, the company operates through two brand categories namely, Nu Skin and Pharmanex. The company offers premium quality personal care products under the Nu Skin brand banner, while nutritional supplements are marketed under Pharmanex. The company has evolved strongly in the skin care treatments arena, more particularly in anti-aging products. Some of the renowned brands of the company in skin care includes ageLOC and Epoch. The company also provides a wide range of hair care and other personal care items. In addition to these, the company offers a diverse range of nutritional and weight management products such as ageLOC Youth nutritional supplement and LifePak nutritional supplements.
|
